INBS — INTELLIGENT BIO SOLUTIONS IN
什么是 13F 持仓报告?谁需要申报、何时申报 · 13F 持仓报告看不到什么
基本面(SEC EDGAR XBRL)
财务数据来自 SEC company facts,每项均按 EDGAR 提交日期做 point-in-time 对齐。
| 营收 TTM | 营收同比 | 净利 TTM | 净利同比 | ROE(TTM) | 毛利率 | 净利率 | 市盈率(TTM) | PE 分位 | 市净率 | PB 分位 |
|---|---|---|---|---|---|---|---|---|---|---|
| $4.5M | +36.5% | -$12.1M | — | -160.2% | 54.5% | -191.0% | — | — | — | — |
营收同比趋势 净利率趋势
华尔街分析师共识
评级、12 个月目标价与 EPS 预期,来自 Nasdaq 公开分析师数据接口。 · 抓取于 2026-11-19
| 财年截止 | 共识 EPS 预期 | 前瞻市盈率 | 最高 EPS | 最低 EPS | 预测机构数 | 近 4 周修正(上调/下调) |
|---|---|---|---|---|---|---|
| Jun 2027 | -5.18 | — | -5.18 | -5.18 | 1 | — |
| Jun 2028 | -4.06 | — | -4.06 | -4.06 | 1 | — |
前瞻市盈率 = 抓取时现价 ÷ 共识 EPS(季度数据 ×4 年化)。修正分 =(上调 − 下调)÷ 预测机构数,来自 Nasdaq 近 4 周统计。 来源: Nasdaq analyst data
最后更新: 2026-11-17 · 来源: SEC EDGAR Form 13F-HR
截至Q3 2026,共 9 家机构在其最新 13F 申报中持有 INBS(INTELLIGENT BIO SOLUTIONS IN),合计申报市值 $201.91K,对应 118.62K 股。按股数计算较上季度减持 6.2%(-2.46K 股),申报市值环比下降 31.7%。持仓集中度较高:前五大持有人占申报市值的 97.6%,前十大的集中度为 100.0%。
与上一季度相比,3 家新建仓位、1 家加仓、3 家减仓、3 家清仓退出。13F 数据为季末快照,以上变动反映的是 Q3 2026 末的持仓状态,并非实时交易。
INTELLIGENT BIO SOLUTIONS IN(INBS)的主要机构持有人包括 Hudson Bay Capital Management LP、ADAR1 Capital Management, LLC、ARMISTICE CAPITAL, LLC,按 13F 申报市值在本页 38 家持有人中排名居前。
INBS 属于Health Care板块。
本页所有数据均来自美国证监会(SEC)13F 季度申报。13F 申报人需在季度结束后 45 天内披露 10 万美元以上的多头持仓;空头、期权对冲与季度内交易不在其列,因此这些数字反映的是机构持仓的季度快照,而非实时仓位。
机构逐季持仓趋势
| 季度 | 持有机构数 | 股数 | 金额 | 环比净变动 |
|---|---|---|---|---|
| Q3 2026 | 9 | 118.62K | $201.91K | -6.2% |
| Q2 2026 | 9 | 202.20K | $464.05K | +6.5% |
| Q1 2026 | 9 | 208.35K | $696.95K | -67.0% |
| Q4 2025 | 7 | 5.66K | $53.02K | -97.3% |
| Q3 2025 | 12 | 1.35M | $1.38M | +21.5% |
| Q2 2025 | 9 | 707.62K | $1.22M | +0.2% |
| Q1 2025 | 9 | 877.16K | $1.26M | +45.3% |
| Q4 2024 | 8 | 76.82K | $107.55K | +24.5% |
表内 8 个季度中,机构持股合计增加 54%(Q4 2024 → Q3 2026);单季变动最大的是 Q4 2025(-97.3%)。
前 25 大机构持仓人(Q3 2026) — 9 家基金
| 基金 | 股数 | 金额 | 组合权重 | 变化 |
|---|---|---|---|---|
| 70.03K | $116.96K | 0.00% | 新进 | |
| 17.88K | $29.86K | 0.00% | 减持 | |
| 11.22K | $22.55K | 0.00% | 新进 | |
| 12.60K | $21.05K | 0.00% | 增持 | |
| 3.96K | $6.61K | 0.00% | 持有 | |
| 1.36K | $2.28K | 0.00% | 减持 | |
| 1.35K | $2.26K | 0.00% | 减持 | |
| 200 | $326 | 0.00% | 持有 | |
| 13 | $21 | 0.00% | 新进 |
更早季度的机构持仓记录(逐季列表): 返回前 25 大机构持仓人
Q2 2026 — 9 家基金
| 基金 | 股数 | 金额 | 组合权重 | 变化 |
|---|---|---|---|---|
| 141.40K | $324.51K | 0.00% | 增持 | |
| 20.84K | $47.83K | 0.00% | 新进 | |
| 20.84K | $47.83K | 0.00% | 减持 | |
| 5.81K | $13.33K | 0.00% | 持有 | |
| 5.74K | $13.16K | 0.00% | 增持 | |
| 3.96K | $9.08K | 0.00% | 持有 | |
| 3.28K | $7.53K | 0.00% | 增持 | |
| 200 | $460 | 0.00% | 持有 | |
| 142 | $326 | 0.00% | 新进 |
Q1 2026 — 9 家基金
| 基金 | 股数 | 金额 | 组合权重 | 变化 |
|---|---|---|---|---|
| 130.00K | $434.85K | 0.01% | 新进 | |
| 37.96K | $126.96K | 0.00% | 新进 | |
| 28.61K | $95.70K | 0.00% | 新进 | |
| 5.81K | $19.43K | 0.00% | 新进 | |
| 3.96K | $13.24K | 0.00% | 新进 | |
| 1.25K | $4.18K | 0.00% | 减持 | |
| 372 | $1.24K | 0.00% | 减持 | |
| 200 | $670 | 0.00% | 新进 | |
| 200 | $669 | 0.00% | 持有 |
Q4 2025 — 7 家基金
| 基金 | 股数 | 金额 | 组合权重 | 变化 |
|---|---|---|---|---|
| 4.05K | $38.63K | 0.00% | 新进 | |
| 1.26K | $12.01K | 0.00% | 新进 | |
| 200 | $996 | 0.00% | 减持 | |
| 76 | $724 | 0.00% | 减持 | |
| 35 | $332 | 0.00% | 减持 | |
| 25 | $238 | 0.00% | 新进 | |
| 9 | $86 | 0.00% | 减持 |
Q3 2025 — 12 家基金
| 基金 | 股数 | 金额 | 组合权重 | 变化 |
|---|---|---|---|---|
| 673.49K | $686.96K | 0.00% | 增持 | |
| 426.43K | $434.96K | 0.04% | 新进 | |
| 97.69K | $99.64K | 0.00% | 增持 | |
| 58.87K | $60.05K | 0.00% | 增持 | |
| 44.69K | $45.59K | 0.01% | 新进 | |
| 25.00K | $25.50K | 0.00% | 新进 | |
| 12.83K | $13.09K | 0.00% | 持有 | |
| 9.35K | $9.54K | 0.00% | 新进 | |
| 2.64K | $2.69K | 0.00% | 增持 | |
| 2.00K | $2.04K | 0.00% | 新进 | |
| 350 | $354 | 0.00% | 持有 | |
| 64 | $65 | 0.00% | 增持 |
Q2 2025 — 9 家基金
| 基金 | 股数 | 金额 | 组合权重 | 变化 |
|---|---|---|---|---|
| 613.89K | $1.06M | 0.00% | 持有 | |
| 51.45K | $88.50K | 0.00% | 增持 | |
| 15.48K | $26.63K | 0.00% | 持有 | |
| 12.83K | $22.06K | 0.00% | 持有 | |
| 10.90K | $18.75K | 0.00% | 新进 | |
| 2.35K | $4.00K | 0.00% | 新进 | |
| 350 | $598 | 0.00% | 新进 | |
| 300 | $516 | 0.00% | 减持 | |
| 63 | $108 | 0.00% | 增持 |
新建仓(Q3 2026)
- Alyeska Investment Group, L.P. 70.03K 股 · $116.96K
- StoneX Group Inc. 11.22K 股 · $22.55K
- JPMorgan Chase & Co 13 股 · $21
完全清仓(较上季)
- ARMISTICE CAPITAL, LLC 卖出 141.40K 股 · $324.51K
- GEODE CAPITAL MANAGEMENT, LLC 卖出 20.84K 股 · $47.83K
- BARCLAYS PLC 卖出 142 股 · $326
基金持仓历史 — 各季度股数(前 20 只基金)
| 基金 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Alyeska Investment Group, L.P. | 70.03K | — | 37.96K | — | 673.49K | 613.89K | 613.89K | — | 206.20K | 222.91K | 206.20K | — | — | — | — | — | — | — | — | — |
| Geode Capital Management | 17.88K | 20.84K | 28.61K | — | 58.87K | 51.45K | 49.01K | 26.60K | 22.71K | 19.06K | 14.32K | 12.41K | 12.41K | — | — | 115.36K | 115.83K | 115.83K | 113.12K | — |
| StoneX Group Inc. | 11.22K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| VANGUARD CAPITAL MANAGEMENT LLC | 12.60K | 5.81K | 5.81K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| VANGUARD FIDUCIARY TRUST CO | 3.96K | 3.96K | 3.96K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| UBS Group AG | 1.36K | 5.74K | 372 | 4.05K | — | 300 | 1.17K | 2.90K | 1.55K | 8.32K | 348 | — | — | — | 613 | 10.76K | 759 | 12.66K | 11.20K | 9.12K |
| Tower Research Capital LLC (TRC) | 1.35K | 3.28K | 1.25K | 1.26K | — | — | — | 5.80K | 1.06K | 654 | 1.05K | 25.35K | 5.95K | — | — | — | — | — | — | — |
| OSAIC HOLDINGS, INC. | 200 | 200 | 200 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| JPMorgan Chase & Co | 13 | — | — | — | — | — | — | — | — | — | 4 | — | — | — | — | — | — | — | — | — |
| ADAR1 Capital Management, LLC | — | — | — | — | 426.43K | — | — | — | 5.39K | 108.25K | 108.25K | — | — | — | — | — | — | — | — | — |
| Hudson Bay Capital Management LP | — | — | — | — | — | — | — | — | — | — | 108.25K | — | — | — | — | — | — | — | — | — |
| ARMISTICE CAPITAL, LLC | — | 141.40K | 130.00K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Altium Capital Management LLC | — | — | — | — | — | — | 149.25K | — | — | 83.91K | — | — | — | — | — | — | — | — | — | — |
| Vanguard Group | — | — | — | — | 97.69K | 15.48K | 15.48K | 15.48K | 15.48K | 15.48K | 15.48K | — | — | — | — | 16.92K | 16.45K | 16.45K | — | 38.92K |
| Renaissance Technologies | — | — | — | — | — | 10.90K | — | — | — | — | — | 147.57K | — | — | — | 104.80K | 107.00K | 111.90K | 67.50K | — |
| Citadel Advisors | — | — | — | — | — | — | — | — | — | — | 14.84K | 156.39K | — | — | — | 69.48K | 34.57K | — | 29.42K | — |
| Virtu Financial LLC | — | — | — | — | — | — | — | — | — | — | 12.54K | — | — | — | — | — | — | — | — | — |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | — | — | — | — | — | — | 35.49K | — | — | — | — | — | — | — | — | — | — | — | — | — |
| GEODE CAPITAL MANAGEMENT, LLC | — | 20.84K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Warberg Asset Management LLC | — | — | — | — | 44.69K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
▲ 低买(基金新建/增持,下一季股价上涨 ≥5%) ▼ 高卖(基金减持,下一季股价下跌 ≥5%)
拖拽/滚轮缩放 · 默认显示最近一年 · 标注来自 13F 申报中的季度基金操作 · 悬停查看详情
常见问题
Which funds hold INBS?
As of 2026-Q3, 9 institutional funds reported holding INBS (INTELLIGENT BIO SOLUTIONS IN) in SEC 13F filings, with a combined reported value of $201.91K.
How many shares of INBS do institutions own?
13F filers reported 118.62K shares of INBS, worth $201.91K in aggregate at the end of 2026-Q3.
Is institutional ownership of INBS rising or falling?
Share counts moved -6.2% versus the prior quarter — distribution.
Who are the top institutional holders of INBS?
The largest 13F holders are Hudson Bay Capital Management LP, ADAR1 Capital Management, LLC, ARMISTICE CAPITAL, LLC, Altium Capital Management LLC, Alyeska Investment Group, L.P.; the top 25 are ranked at the top of this page.
Who are the major shareholders of INTELLIGENT BIO SOLUTIONS IN?
The major shareholders of INTELLIGENT BIO SOLUTIONS IN (INBS) by reported 13F value are Hudson Bay Capital Management LP, ADAR1 Capital Management, LLC, ARMISTICE CAPITAL, LLC, Altium Capital Management LLC, Alyeska Investment Group, L.P., among 38 institutional holders.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.